Upregulation of the immune checkpoints CD155 and CD47 was observed on cKit+ malignant cells from Vav-cre Tet2fl/flTp53fl/fl mice and in myeloid malignant cells from patients with TP53/TET2 double-mutant AML. This evidence concerns the gene TP53 and acute myeloid leukemia.